BioSpace News Archive

Drug Development

Gannex Announces Positive Topline Results of the U.S. Phase I Trial of NASH Drug ASC42, an FXR Agonist

Gannex today announces positive topline results of safety and pharmacodynamic biomarkers from the U.S. Phase I trial of NASH drug farnesoid X receptor (FXR) agonist ASC42.

June 16, 2021
·
4 min read
BioMidwest

Aruvant Partners with Aldevron to Provide Key Plasmid Raw Materials Used to Manufacture Pipeline Products

Aruvant Sciences and Aldevron announced that Aldevron will support the development of ARU-1801, Aruvant’s one-time investigational gene therapy for sickle cell disease, and ARU-2801, a one-time investigational gene therapy for hypophosphatasia.

June 16, 2021
·
5 min read
Biotech Bay

Mirum Pharmaceuticals to Showcase Analyses From Its Rare Liver Disease Programs at The International Liver Congress 2021

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced its participation in The International Liver Congress™ taking place virtually June 23-26, 2021

June 16, 2021
·
6 min read
Drug Development

Starton Therapeutics Phase 2 TROPIC-I Clinical Study will be First to Use Total Control Primary Endpoint in Superiority StudySTAR-OLZ for acute and delayed chemotherapy induced nausea and vomiting (CINV)

Starton Therapeutics Inc. announces Type C Meeting Responses from the US Food and Drug Administration (FDA) leading to the finalization of the Company’s clinical development approach for STAR-OLZ in Chemotherapy Induced Nausea and Vomiting (CINV).

June 16, 2021
·
5 min read
Pharm Country

electroCore to Join Russell Microcap® Index

electroCore, Inc. announced today the addition of its stock to the broad-market Russell Microcap ® Index after its 2021 annual reconstitution, effective after the open of trading on June 28, 2021.

June 16, 2021
·
3 min read
Biotech Bay

Pamrevlumab Included in Pancreatic Cancer Action Network’s Adaptive Clinical Trial Platform

FibroGen, Inc. (NASDAQ: FGEN) announced activation of an experimental arm in the Pancreatic Cancer Action Network’s (PanCAN) Precision PromiseSM adaptive trial platform evaluating pamrevlumab [and standard of care] for patients with metastatic pancreatic cancer.

June 16, 2021
·
6 min read
Biotech Bay

BriaCell Therapeutics Expands Breast Cancer Platform Technology into Prostate, Melanoma, and Lung Cancers

BriaCell is expanding its breast cancer platform technology into other cancers including prostate, melanoma, and non-small cell lung cancer.

June 16, 2021
·
4 min read
Motus GI Announces First Patients Enrolled in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients With a History of Poor Bowel Preparation

Motus GI Holdings, Inc. announced today enrollment of the first patients in the European Union (EU) study of the Pure-Vu System.

June 16, 2021
·
6 min read
Business

BeyondSpring Announces First Quarter 2021 Financial Results and Provides a Corporate Update

BeyondSpring today announced its financial results for the first quarter ended March 31, 2021 and provided an update on recent corporate events.

June 16, 2021
·
10 min read
BioCapital

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

Veralox Therapeutics today announced the closing of a $16.6 million Series A financing.

June 16, 2021
·
2 min read